An essential SMN interacting protein (SIP1) is not involved in the phenotypic variability of spinal muscular atrophy (SMA)

被引:12
|
作者
Helmken, C
Wetter, A
Rudnik-Schöneborn, S
Liehr, T
Zerres, K
Wirth, B
机构
[1] Inst Human Genet, D-53111 Bonn, Germany
[2] Inst Human Genet, Aachen, Germany
[3] Inst Anthropol & Human Genet, Jena, Germany
关键词
SMN interacting protein 1 (SIP1); survival motor neuron gene (SMN1); spinal muscular atrophy (SMA); genomic structure; physical location; molecular analysis; neuromuscular disease; mutation analysis;
D O I
10.1038/sj.ejhg.5200479
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The survival motor neuron (SMN) protein and the SMN interacting protein 1 (SIP1) are part of a 300 kD protein complex with a crucial role in snRNP biogenesis and pre-mRNA splicing. Both proteins are colocalised in nuclear structures called gems and in the cytoplasm. Approximately 96% of patients with autosomal recessive spinal muscular atrophy (SMA) show mutations in the SMN1 gene, while about 4% fail to show any mutation, despite a typical SMA phenotype. Additionally, sibs with identical 5q13 homologs and homozygous absence of SMN1 can show variable phenotypes which suggest that SMA is modified by other, yet unknown factors. Since both genes, SMN1 and SIP1, belong to the same pathway and are part of the same protein complex, it is obvious to ask whether mutations within SIP1 are responsible for both the phenotypic variability and the appearance of non-SMN mutated SMA patients. First, we identified the chromosomal location of SIP1 and assigned it to chromosomal region 14q13-q21 by fluorescence in situ hybridisation. No SMA related disorder has yet been assigned to this chromosomal region. Next, we determined the exon-intron structure of the SIP1 gene which encompasses 10 exons and identified five transcription isoforms. We sequenced either RT-PCR products or genomic DNA covering the complete coding region from 23 typical SMA patients who had failed to show any SMN1 mutation. No mutation and no polymorphism was found within SIP1. Additionally, we sequenced RT-PCR products or genomic fragments of the entire SIP1 coding region from 26 sibs of 11 SMA families with identical genotypes (Delta 7SMN/Delta 7SMN or Delta 7SMN/other mutation) but different phenotypes and again no mutation was found. Finally, we performed quantitative analysis of RT-PCR products from the same 26 sibs. No difference in expression level of the five isoforms among phenotypically variable sibs was observed. Based on these data, we suggest that neither the phenotypic variability nor the 5q-unlinked SMA are caused by mutations within SIP1.
引用
收藏
页码:493 / 499
页数:7
相关论文
共 50 条
  • [41] Spinal muscular atrophy carriers with two SMN1 copies
    Rochmah, Mawaddah Ar
    Awano, Hiroyuki
    Awaya, Tomonari
    Harahap, Nur Imma Fatimah
    Morisada, Naoya
    Bouike, Yoshihiro
    Saito, Toshio
    Kubo, Yuji
    Saito, Kayoko
    Lai, Poh San
    Morioka, Ichiro
    Iijima, Kazumoto
    Nishio, Hisahide
    Shinohara, Masakazu
    BRAIN & DEVELOPMENT, 2017, 39 (10): : 851 - 860
  • [42] Spinal Muscular Atrophy and the Antiapoptotic Role of Survival of Motor Neuron (SMN) Protein
    Anderton, Ryan S.
    Meloni, Bruno P.
    Mastaglia, Frank L.
    Boulos, Sherif
    MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 821 - 832
  • [43] Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy
    Anderton, Ryan S.
    Meloni, Bruno P.
    Mastaglia, Frank L.
    Boulos, Sherif
    TRANSLATIONAL NEUROSCIENCE, 2014, 5 (01) : 8 - 16
  • [44] Spinal Muscular Atrophy and the Antiapoptotic Role of Survival of Motor Neuron (SMN) Protein
    Ryan S. Anderton
    Bruno P. Meloni
    Frank L. Mastaglia
    Sherif Boulos
    Molecular Neurobiology, 2013, 47 : 821 - 832
  • [45] Nusinersen: antisense oligonucleotide to increase SMN protein production in spinal muscular atrophy
    Paton, D. M.
    DRUGS OF TODAY, 2017, 53 (06) : 327 - 337
  • [46] SMN deficiency alters the CNS and the peripheral immune system in a mouse model of spinal muscular atrophy (SMA)
    Khairallah, Marie-Therese
    Franklin, Craig
    Simon, Madeline
    O'Day, Siri
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [47] Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells
    Angelozzi, C.
    Borgo, F.
    Tiziano, F. D.
    Martella, A.
    Neri, G.
    Brahe, C.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (01) : 29 - 31
  • [48] Analysis of the main spinal muscular atrophy (SMA) candidate genes - SMN and NAIP - in patients from Slovakia
    Zatkova, A
    Hahnen, E
    Wirth, B
    Kadasi, L
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 129 - 129
  • [49] Coupled in vitro import of U snRNPs and SMN, the spinal muscular atrophy protein
    Narayanan, U
    Achsel, T
    Lührmann, R
    Matera, AG
    MOLECULAR CELL, 2004, 16 (02) : 223 - 234
  • [50] Salbutamol Increases SMN mRNA in Spinal Muscular Atrophy Patients (SMA): Relevance for Clinical Trial Design
    Tiziano, Francesco D.
    Lomastro, Rosa
    Pinto, Anna Maria
    Messina, Sonia
    D'Amico, Adele
    Fiori, Stefania
    Angelozzi, Carla
    Pane, Marika
    Mercuri, Eugenio
    Bertini, Enrico
    Neri, Giovanni
    Brahe, Christina
    NEUROLOGY, 2010, 74 (09) : A332 - A332